Form 4: Moderna Director Elizabeth Nabel Reports Stock Transactions

Director Elizabeth G. Nabel reports acquisition and disposal of Moderna (MRNA) common stock and restricted stock units.

Summary

• On April 30, 2025, Elizabeth G. Nabel, a director of Moderna, Inc., reported transactions involving the company's stock.
• Nabel acquired 3,084 shares of common stock.
• She also disposed of 979 shares of common stock.
• These transactions involved the conversion of restricted stock units into common stock.
• Following these transactions, Nabel directly owns 16,233 restricted stock units.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.

Future Outlook

The shares subject to the restricted stock unit award will vest in full on the earlier of April 30, 2026, or Moderna's next Annual Meeting of Shareholders, subject to the recipient's continued service.

Industry Context

This is a routine disclosure of stock transactions by a company insider, which is common for publicly traded companies like Moderna. It provides transparency to investors regarding the trading activities of key personnel.

Stakeholder Impact

• The transactions provide transparency to shareholders regarding insider trading activity.
• The vesting schedule of restricted stock units incentivizes continued service of the director.

Key Dates

Keywords

Moderna, MRNA, Elizabeth Nabel, Director, Stock Transactions, Form 4, Restricted Stock Units, Common Stock, SEC Filing